Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significance » significantly (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significance » significantly (Expand Search)
-
1841
-
1842
-
1843
Unsupervised hierarchical clustering for benign samples only (nontreatment, STT, and LTT groups).
Published 2025Subjects: -
1844
-
1845
-
1846
Combined Morphological and IHC Data: Combined Morphological and Immunohistochemistry Data.
Published 2025Subjects: -
1847
-
1848
Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x).
Published 2025Subjects: -
1849
-
1850
-
1851
-
1852
Restricted cubic spline plots showing the association between changes in PAL and risk of CVD.
Published 2025Subjects: -
1853
Logistic Regression Analysis of the Association between PALs (MET-minutes/week) and CVD.
Published 2025Subjects: -
1854
-
1855
IHC Scores computer image analysis: Immunohistochemistry Scores and computer image analysis.
Published 2025Subjects: -
1856
-
1857
-
1858
-
1859
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
1860